Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Due to overwhelming demand for our April 28 "Strategic Alliances: Pot of Gold or Pretty Poison?" event, we will be holding another round on Wednesday, June 28 at the Cambridge Innovation Center (CIC). Moderated by corporate attorney John Hession, a panel of business development experts will explore various research and collaboration structures, from options to license to comprehensive …

Continue reading Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Panel 3 of Life Sciences Series To Be Held On September 22nd!

On Thursday, September 22nd, MBBP will host the third panel of our Life Sciences Series, "Funding Models in Biotech".  The panel will be held at the Cambridge Innovation Center (CIC) from 4:30pm - 6:00pm. The panel will discuss today's financing environment for emerging biotech companies, and the many complexities facing these companies in their attempts …

Continue reading Panel 3 of Life Sciences Series To Be Held On September 22nd!

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Managing Partner Lisa Warren Moderating Entrepreneur’s University: Acquiring IP

Lisa Warren will be serving as a Co-Moderator for the upcoming, "Entrepreneur's University: Acquiring IP" program organized by MassBio Entrepreneur's University Working Group. Entrepreneur University hosts forums to help entrepreneurs thrive in today's competitive biotech environment.  During this program specifically, industry experts will share critical advice for entrepreneurs who are setting out to acquire their intellectual property. The …

Continue reading Managing Partner Lisa Warren Moderating Entrepreneur’s University: Acquiring IP

Boston Growing Hub for the Life Sciences Industry

The Boston Business Journal just announced that at the annual Biotechnology Innovation Organization meeting, Boston was recognized as the city with the largest number of employers in the field of research testing and medical laboratories.  The BBJ explains that from biotech giants such as Biogen to Genzyme to research labs at the prestigious Harvard and MIT, …

Continue reading Boston Growing Hub for the Life Sciences Industry

MBBP Client Selvita Establishes First U.S. Operations in Greater Boston Area

MBBP client, Selvita, recently announced an expansion into the Boston-area biotechnology and pharmaceutical market, as they open a fully-owned US subsidiary, Selvita Inc., headquartered in Cambridge, Massachusetts. Selvita is a leading global drug discovery company and the largest drug discovery company in Central and Eastern Europe. The new office, located at 485 Massachusetts Ave., will focus …

Continue reading MBBP Client Selvita Establishes First U.S. Operations in Greater Boston Area

MBBP’s Joanna Brougher 2014 National Law Journal Rising Star

 MBBP’s Joanna Brougher was selected for the 2014 National Law Journal's list of Boston's Rising Stars. The National Law Journal Rising Stars program recognizes the region's 40 most promising lawyers age 40 and under.  Joanna graduated from the University of Rochester with a B.S. in Microbiology, a B.A. in German, and a masters in public health. …

Continue reading MBBP’s Joanna Brougher 2014 National Law Journal Rising Star

Boston Business Journal Revisits Local Biotech IPO’s: “Where are They Now?

On March 7, the Boston Business Journal (BBJ) published an article titled "A year of biotech IPOs: Where is their stock price now?" which highlights fourteen local biotech companies that went public last year, ranking them by their stock increase seen since the close of their first day on the market until the March 6 close. A year …

Continue reading Boston Business Journal Revisits Local Biotech IPO’s: “Where are They Now?